BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15787292)

  • 1. [Genetics of Alzheimer disease].
    Verkkoniemi A; Kalimo H; Viitanen M
    Duodecim; 2005; 121(3):326-7; author reply 327. PubMed ID: 15787292
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetics of Alzheimer's disease].
    Hiltunen M; Helisalmi S; Kivipelto M; Soininen H
    Duodecim; 2004; 120(20):2425-31. PubMed ID: 15641511
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic testing and Alzheimer disease: the promise.
    Roses AD
    Alzheimer Dis Assoc Disord; 1998; 12 Suppl 3():S3-9. PubMed ID: 9876936
    [No Abstract]   [Full Text] [Related]  

  • 4. The Thr354Ile substitution in PSEN1:: disease-causing mutation or polymorphism?
    Lee P; Medina L; Ringman JM
    Neurology; 2006 Jun; 66(12):1955-6. PubMed ID: 16801675
    [No Abstract]   [Full Text] [Related]  

  • 5. Family history of dementia in early-onset versus very late-onset Alzheimer's disease.
    McMurtray AM; Ringman J; Chao SZ; Licht E; Saul RE; Mendez MF
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):597-8. PubMed ID: 16783800
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
    Brouwers N; Sleegers K; Engelborghs S; Maurer-Stroh S; Gijselinck I; van der Zee J; Pickut BA; Van den Broeck M; Mattheijssens M; Peeters K; Schymkowitz J; Rousseau F; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C
    Neurology; 2008 Aug; 71(9):656-64. PubMed ID: 18565828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
    Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
    Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
    J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and dementia nosology.
    Blacker D; Lovestone S
    J Geriatr Psychiatry Neurol; 2006 Sep; 19(3):186-91. PubMed ID: 16880361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
    Borroni B; Di Luca M; Padovani A
    Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline.
    Moonis M; Swearer JM; Dayaw MP; St George-Hyslop P; Rogaeva E; Kawarai T; Pollen DA
    Neurology; 2005 Jul; 65(2):323-5. PubMed ID: 16043812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting Alzheimer disease before it happens: The key to prevention?
    Quinn J; Sabbagh MN
    Neurology; 2008 Jul; 71(2):78-9. PubMed ID: 18606962
    [No Abstract]   [Full Text] [Related]  

  • 13. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.
    Brickell KL; Steinbart EJ; Rumbaugh M; Payami H; Schellenberg GD; Van Deerlin V; Yuan W; Bird TD
    Arch Neurol; 2006 Sep; 63(9):1307-11. PubMed ID: 16966510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer pathology associated with POLG1 mutation, multiple mtDNA deletions, and APOE4/4: premature ageing or just coincidence?
    Melberg A; Nennesmo I; Moslemi AR; Kollberg G; Luoma P; Suomalainen A; Holme E; Oldfors A
    Acta Neuropathol; 2005 Sep; 110(3):315-6. PubMed ID: 15981013
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
    van der Flier WM; Schoonenboom SN; Pijnenburg YA; Fox NC; Scheltens P
    Neurology; 2006 Aug; 67(3):526-7. PubMed ID: 16894123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children of Alzheimer patients: an overview.
    Jarvik LF; Blazer D
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):181-6. PubMed ID: 16306236
    [No Abstract]   [Full Text] [Related]  

  • 17. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease.
    Ponomareva NV; Korovaitseva GI; Rogaev EI
    Neurobiol Aging; 2008 Jun; 29(6):819-27. PubMed ID: 17293007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics of Alzheimer's disease].
    Lambert JC
    Rev Prat; 2011 Sep; 61(7):922-3. PubMed ID: 22039726
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.
    Hulette CM; Welsh-Bohmer K
    Neurology; 2007 Feb; 68(6):471; author reply 471. PubMed ID: 17283328
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutation negative "early-onset familial Alzheimer disease": consider screening for tau gene mutations.
    Larner AJ
    Alzheimer Dis Assoc Disord; 2008; 22(2):194-5. PubMed ID: 18525295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.